These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9617622)

  • 1. [Prognostic significance of clinical stage including extent of disease (EOD) in prostate cancer].
    Fujinami K; Kondo I; Miura T; Harada M; Uemura H; Hosaka M; Kawasaki C
    Hinyokika Kiyo; 1998 Apr; 44(4):259-63. PubMed ID: 9617622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical analysis of 169 patients with prostate cancer].
    Okaneya T; Mizusawa H; Yoneyama T; Taguchi I; Komiyama I; Kawakami M; Hosaka K; Tsuruta T; Murata Y; Komatsu H; Misawa K; Kiyokawa H
    Hinyokika Kiyo; 1996 Aug; 42(8):563-7. PubMed ID: 8889563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study of prostate cancer--statistical analysis in the last 10 years].
    Yamamoto N; Shimabukuro T; Matsuyama H; Yoshihiro S; Mitsui H; Sakatoku J
    Hinyokika Kiyo; 1991 Jul; 37(7):705-10. PubMed ID: 1927770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination therapy with estrogen and UFT in newly diagnosed prostatic cancer (poorly differentiated, stage D2)].
    Kondo I; Miura T; Fujii H; Harada M; Fukushima S; Kubota Y; Hosaka M
    Hinyokika Kiyo; 1996 Mar; 42(3):201-6. PubMed ID: 8619389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between histologic grading and prognosis of prostatic cancer--comparing the grading system of the Japanese general rules of prostatic cancer with Gleason's grading].
    Hioki T; Sugimura Y; Sakurai M; Hayashi N; Tochigi H; Kawamura J; Yatani R
    Hinyokika Kiyo; 1990 Aug; 36(8):921-6. PubMed ID: 2239593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum interleukin 6 as a prognostic factor in patients with prostate cancer.
    Nakashima J; Tachibana M; Horiguchi Y; Oya M; Ohigashi T; Asakura H; Murai M
    Clin Cancer Res; 2000 Jul; 6(7):2702-6. PubMed ID: 10914713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4.
    Lau WK; Blute ML; Bostwick DG; Weaver AL; Sebo TJ; Zincke H
    J Urol; 2001 Nov; 166(5):1692-7. PubMed ID: 11586204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study of prostate cancer: statistical analysis of 107 cases in the past 12 years].
    Umeda Y; Hayashi N; Ogawa K; Kuromatsu I; Franco OE; Su J; Yamakawa K; Arima K; Yanagawa M; Kawamura J
    Hinyokika Kiyo; 2000 Dec; 46(12):873-8. PubMed ID: 11211803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
    Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
    J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study on adenocarcinoma of the prostate].
    Yamamoto A; Yuasa M; Imagawa A; Kagawa S; Kurokawa K
    Hinyokika Kiyo; 1987 Dec; 33(12):2050-4. PubMed ID: 3448932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of tegafur administration combined with hormonal therapy in patients with newly diagnosed stage D prostatic cancer].
    Kobayashi N; Yoshida K; Takahashi T; Saitoh H; Tari K; Satake I; Kojima S; Tsujii T; Negishi T; Horiuchi S
    Hinyokika Kiyo; 1990 Jul; 36(7):793-800. PubMed ID: 2239576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of 683 prostatic cancer patients in the Tokai Urological Cancer Registry].
    Obata JK; Kuriyama M; Fujita K; Sakai S; Okishio N; Sakagami H; Higashino I; Miyake K
    Hinyokika Kiyo; 1996 Jul; 42(7):503-7. PubMed ID: 8809558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical studies on recurrent prostatic cancer].
    Suzuki K; Nakamura T; Kato N; Suzuki T; Imai K; Yamanaka H
    Hinyokika Kiyo; 1991 Jun; 37(6):595-600. PubMed ID: 1892007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of incidental prostatic carcinoma].
    Maeda O; Saiki S; Kinouchi T; Kuroda M; Miki T; Usami M; Kotake T
    Hinyokika Kiyo; 1991 Feb; 37(2):135-9. PubMed ID: 2048491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of total prostatectomy for prostatic cancer].
    Fujii A; Gohji K; Morisue K; Maruyama S; Kizaki T; Oka N
    Hinyokika Kiyo; 1994 Feb; 40(2):111-7. PubMed ID: 8128919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognosis of prostate cancer with elevated prostatic acid phosphatase].
    Saito T; Kitamura Y; Komatsubara S
    Hinyokika Kiyo; 2006 Mar; 52(3):177-80. PubMed ID: 16617869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CAG polymorphic repeat length in androgen receptor gene combined with pretreatment serum testosterone level as prognostic factor in patients with metastatic prostate cancer.
    Shimbo M; Suzuki H; Kamiya N; Imamoto T; Komiya A; Ueda T; Watanabe M; Shiraishi T; Ichikawa T
    Eur Urol; 2005 Apr; 47(4):557-63. PubMed ID: 15774258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of pulmonary metastases in stage D2 prostate cancer patients.
    Nakamachi H; Suzuki H; Akakura K; Imamoto T; Ueda T; Ishihara M; Furuya Y; Ichikawa T; Igarashi T; Ito H
    Prostate Cancer Prostatic Dis; 2002; 5(2):159-63. PubMed ID: 12497007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors.
    Martinez A; Gonzalez J; Spencer W; Gustafson G; Kestin L; Kearney D; Vicini FA
    J Urol; 2003 Mar; 169(3):974-9; discussion 979-80. PubMed ID: 12576825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.